drugset / Trial / NCT00731562

An Investigation Of The Effects Of Food On The Absorption Of A Varenicline Controlled Release Formulation

NCT00731562

Phase 1 Completed 24 enrolled Pfizer
RandomizedCrossoverOpen-label

Summary

1. To estimate the absorption of a single oral dose of a controlled release varenicline tablet under fed and fasted conditions. 2. To evaluate the pharmacokinetics, safety, and tolerability of a single dose of a varenicline controlled release tablet under fed and fasted conditions.

Timeline

Start
2008-07
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Varenicline Small molecule 2.4 mg Oral

Indications

No indication recorded.